A Covid vaccine linked to a very rare but serious side-effect has been quietly discontinued in Australia, the federal government has confirmed.
The disorder, called thrombosis with thrombocytopenia (TTS), involves blood clots combined with low levels of blood platelets with people under 60 more at risk.
The AstraZeneca Covid vaccine, sold under the brand name Vaxzevria, has not been available to the Australian public since March 20.
The Department of Health and Aged Care confirmed the news in a statement, saying although the vaccine remains provisionally approved in the country, AstraZeneca has decided to “formally discontinue Vaxzevria in Australia”.
Of course, the American mainstream media is dead silent on this development.
The change came after a number of cases of TSS among those aged 50-59 years, and the death of a 52-year-old woman from a blood clot likely linked to the AstraZeneca vaccine.
